• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结缔组织生长因子在骨骼中的过度表达会损害骨形成并导致骨质减少。

Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia.

作者信息

Smerdel-Ramoya Anna, Zanotti Stefano, Stadmeyer Lisa, Durant Deena, Canalis Ernesto

机构信息

Department of Research, Saint Francis Hospital and Medical Center, 114 Woodland Street, Hartford, Connecticut 06105-1299, USA.

出版信息

Endocrinology. 2008 Sep;149(9):4374-81. doi: 10.1210/en.2008-0254. Epub 2008 Jun 5.

DOI:10.1210/en.2008-0254
PMID:18535099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2553373/
Abstract

Connective tissue growth factor (CTGF), a member of the CCN family of proteins, is expressed in skeletal cells, and the ctgf null mutation leads to neonatal lethality due to defects in skeletal development. To define the function of CTGF in the postnatal skeleton, we created transgenic mice overexpressing CTGF under the control of the human osteocalcin promoter. CTGF transgenic female and male mice exhibited a significant decrease in bone mineral density, compared with wild-type littermate controls. Bone histomorphometry revealed that CTGF overexpression caused decreased trabecular bone volume due to impaired osteoblastic activity because mineral apposition and bone formation rates were decreased. Osteoblast and osteoclast number and bone resorption were not altered. Calvarial osteoblasts and stromal cells from CTGF transgenics displayed decreased alkaline phosphatase and osteocalcin mRNA levels and reduced bone morphogenetic protein (BMP) signaling mothers against decapentaplegic, Wnt/beta-catenin, and IGF-I/Akt signaling. In conclusion, CTGF overexpression in vivo causes osteopenia, secondary to decreased bone formation, possibly by antagonizing BMP, Wnt, and IGF-I signaling and activity.

摘要

结缔组织生长因子(CTGF)是CCN蛋白家族的成员之一,在骨骼细胞中表达,ctgf基因敲除突变会因骨骼发育缺陷导致新生小鼠死亡。为了确定CTGF在出生后骨骼中的功能,我们构建了在人骨钙素启动子控制下过表达CTGF的转基因小鼠。与野生型同窝对照相比,CTGF转基因雌雄小鼠的骨矿物质密度显著降低。骨组织形态计量学显示,由于成骨细胞活性受损,CTGF过表达导致小梁骨体积减少,因为矿物质沉积和骨形成率降低。成骨细胞和破骨细胞数量以及骨吸收未发生改变。来自CTGF转基因小鼠的颅骨成骨细胞和基质细胞显示碱性磷酸酶和骨钙素mRNA水平降低,骨形态发生蛋白(BMP)信号通路、Wnt/β-连环蛋白信号通路以及IGF-I/Akt信号通路减弱。总之,体内CTGF过表达会导致骨质减少,继发于骨形成减少,可能是通过拮抗BMP、Wnt和IGF-I信号通路及活性实现的。

相似文献

1
Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia.结缔组织生长因子在骨骼中的过度表达会损害骨形成并导致骨质减少。
Endocrinology. 2008 Sep;149(9):4374-81. doi: 10.1210/en.2008-0254. Epub 2008 Jun 5.
2
Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia.肾母细胞瘤过表达基因(Nov)抑制成骨细胞生成并导致骨质减少。
J Biol Chem. 2007 Jul 6;282(27):19762-72. doi: 10.1074/jbc.M700212200. Epub 2007 May 10.
3
Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice.结缔组织生长因子对于雄性小鼠的骨骼发育和出生后骨骼内稳态是必需的。
Endocrinology. 2010 Aug;151(8):3490-501. doi: 10.1210/en.2010-0145. Epub 2010 Jun 9.
4
Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells.结缔组织生长因子(CTGF)在间充质干细胞向成骨细胞分化过程中受Wnt和骨形态发生蛋白信号通路的调控。
J Biol Chem. 2004 Dec 31;279(53):55958-68. doi: 10.1074/jbc.M407810200. Epub 2004 Oct 20.
5
Skeletal overexpression of gremlin impairs bone formation and causes osteopenia.Gremlin基因在骨骼中的过表达会损害骨形成并导致骨质减少。
Endocrinology. 2005 Feb;146(2):655-65. doi: 10.1210/en.2004-0766. Epub 2004 Nov 11.
6
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.Dkk1介导的骨中Wnt信号抑制导致骨质减少。
Bone. 2006 Oct;39(4):754-66. doi: 10.1016/j.bone.2006.03.017. Epub 2006 May 26.
7
Notch inhibits osteoblast differentiation and causes osteopenia.Notch抑制成骨细胞分化并导致骨质减少。
Endocrinology. 2008 Aug;149(8):3890-9. doi: 10.1210/en.2008-0140. Epub 2008 Apr 17.
8
Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo.结缔组织生长因子在骨中的表达:其在体外成骨细胞增殖与分化及体内骨形成中的作用
J Cell Physiol. 2003 Jul;196(1):51-62. doi: 10.1002/jcp.10319.
9
Connective tissue growth factor enhances osteoblastogenesis in vitro.结缔组织生长因子在体外增强成骨细胞生成。
J Biol Chem. 2008 Aug 15;283(33):22690-9. doi: 10.1074/jbc.M710140200. Epub 2008 Jun 25.
10
Conditional disruption of Pkd1 in osteoblasts results in osteopenia due to direct impairment of bone formation.条件性敲除成骨细胞中的 Pkd1 会因直接损害骨形成而导致骨质疏松。
J Biol Chem. 2010 Jan 8;285(2):1177-87. doi: 10.1074/jbc.M109.050906. Epub 2009 Nov 3.

引用本文的文献

1
Sexual dimorphism of MASLD-driven bone loss.代谢相关脂肪性肝病(MASLD)所致骨质流失的性别差异。
Sci Rep. 2025 Jul 2;15(1):23090. doi: 10.1038/s41598-025-08693-w.
2
CCN Proteins as Matricellular Regulators of Bone in Aging and Disease.CCN蛋白作为衰老和疾病中骨骼的基质细胞调节因子。
Curr Osteoporos Rep. 2025 May 23;23(1):23. doi: 10.1007/s11914-025-00915-4.
3
Sexual dimorphism of MASLD-driven bone loss.代谢相关脂肪性肝病(MASLD)所致骨质流失的性别差异。
bioRxiv. 2024 Nov 28:2024.11.25.625246. doi: 10.1101/2024.11.25.625246.
4
Blocking CCN2 Reduces Established Bone Loss Induced by Prolonged Intense Loading by Increasing Osteoblast Activity in Rats.通过增强大鼠成骨细胞活性,阻断CCN2可减轻长期高强度负荷诱导的已形成的骨质流失。
JBMR Plus. 2023 Jun 16;7(9):e10783. doi: 10.1002/jbm4.10783. eCollection 2023 Sep.
5
Functions of Matricellular Proteins in Dental Tissues and Their Emerging Roles in Orofacial Tissue Development, Maintenance, and Disease.细胞基质蛋白在牙齿组织中的功能及其在口腔颌面部组织发育、维持和疾病中的新作用。
Int J Mol Sci. 2021 Jun 21;22(12):6626. doi: 10.3390/ijms22126626.
6
CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis.骨髓微环境中的CCN2(细胞通讯网络因子2)、正常造血与恶性造血
J Cell Commun Signal. 2021 Mar;15(1):25-56. doi: 10.1007/s12079-020-00602-2. Epub 2021 Jan 11.
7
Flavonoid compound icariin enhances BMP-2 induced differentiation and signalling by targeting to connective tissue growth factor (CTGF) in SAMP6 osteoblasts.黄酮类化合物淫羊藿苷通过靶向 SAMP6 成骨细胞中的结缔组织生长因子 (CTGF) 增强 BMP-2 诱导的分化和信号转导。
PLoS One. 2018 Jul 10;13(7):e0200367. doi: 10.1371/journal.pone.0200367. eCollection 2018.
8
The BMP-2 mutant L51P: a BMP receptor IA binding-deficient inhibitor of noggin.BMP-2 突变体 L51P:一种 Noggin 结合缺陷的 BMP 受体 IA 抑制剂。
J Bone Miner Metab. 2019 Mar;37(2):199-205. doi: 10.1007/s00774-018-0925-0. Epub 2018 Apr 17.
9
Restoration of murine femoral segmental defect using CTGF-overexpressing MC3T3-E1 cells.使用过表达CTGF的MC3T3-E1细胞修复小鼠股骨节段性缺损
Am J Transl Res. 2016 Mar 15;8(3):1530-40. eCollection 2016.
10
WNT1-induced Secreted Protein-1 (WISP1), a Novel Regulator of Bone Turnover and Wnt Signaling.WNT1诱导分泌蛋白1(WISP1),一种骨转换和Wnt信号传导的新型调节因子。
J Biol Chem. 2015 May 29;290(22):14004-18. doi: 10.1074/jbc.M114.628818. Epub 2015 Apr 11.

本文引用的文献

1
Skeletal actions of insulin-like growth factors.胰岛素样生长因子的骨骼作用。
Expert Rev Endocrinol Metab. 2006 Jan;1(1):47-56. doi: 10.1586/17446651.1.1.47.
2
Connective tissue growth factor enhances osteoblastogenesis in vitro.结缔组织生长因子在体外增强成骨细胞生成。
J Biol Chem. 2008 Aug 15;283(33):22690-9. doi: 10.1074/jbc.M710140200. Epub 2008 Jun 25.
3
Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice.PECAM-1基因缺陷小鼠视网膜血管发育和新生血管形成的减弱
Dev Biol. 2008 Mar 1;315(1):72-88. doi: 10.1016/j.ydbio.2007.12.008. Epub 2008 Jan 22.
4
Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis.在基于细胞的蛋白质组学筛选中鉴定由基质金属蛋白酶2(MMP-2)加工的候选血管生成抑制剂:MMP-2蛋白水解对血管内皮生长因子(VEGF)/肝素亲和调节肽(多效生长因子)和VEGF/结缔组织生长因子血管生成抑制复合物的破坏
Mol Cell Biol. 2007 Dec;27(24):8454-65. doi: 10.1128/MCB.00821-07. Epub 2007 Oct 1.
5
Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice.在结缔组织生长因子(CTGF)基因敲除小鼠中,血管生成并未受损。
J Histochem Cytochem. 2007 Nov;55(11):1139-47. doi: 10.1369/jhc.7A7258.2007. Epub 2007 Jul 11.
6
Bone morphogenetic proteins and their antagonists.骨形态发生蛋白及其拮抗剂。
Rev Endocr Metab Disord. 2006 Jun;7(1-2):51-65. doi: 10.1007/s11154-006-9000-6.
7
Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.扭转型原肠形成蛋白,一种骨形态发生蛋白激动剂/拮抗剂,对于出生后的骨骼功能并非必需。
Bone. 2006 Dec;39(6):1252-60. doi: 10.1016/j.bone.2006.06.028. Epub 2006 Aug 24.
8
Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity.体内NFAT信号的激活会导致骨质减少,这与破骨细胞生成增加和骨吸收活性增强有关。
J Immunol. 2006 Aug 15;177(4):2384-90. doi: 10.4049/jimmunol.177.4.2384.
9
Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.结缔组织生长因子对缺氧诱导因子1α降解及肿瘤血管生成的影响。
J Natl Cancer Inst. 2006 Jul 19;98(14):984-95. doi: 10.1093/jnci/djj242.
10
Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.Dkk1基因单个等位基因的缺失会导致骨形成和骨量增加。
J Bone Miner Res. 2006 Jun;21(6):934-45. doi: 10.1359/jbmr.060311.